中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

44 records (took 0.039 seconds)

    Production of a zeolite-containing solid
    1.
    发明申请
    Production of a zeolite-containing solid 审中-公开
    制备含沸石的固体

    公开(公告)号：US20060183629A1

    公开(公告)日：2006-08-17

    申请号：US11044195

    申请日：2005-01-28

    Applicant: Ulrich Muller ,  Hartwig Voss ,  Erich Schubert ,  Friedrich Hill ,  Hermann Petersen

    Inventor： Ulrich Muller ,  Hartwig Voss ,  Erich Schubert ,  Friedrich Hill ,  Hermann Petersen

    IPC: B01J29/04

    CPC classification number: C01B21/1409 ,  B01J29/04 ,  B01J29/06 ,  B01J29/89 ,  C01B39/026 ,  C07C239/08 ,  C07C249/04 ,  C07D301/12

    Abstract: In a process for concentrating an at least partially crystalline solid containing at least one zeolite in a mixture comprising at least one auxiliary, for example a template compound, and said solid, the mixture is ultrafiltrated in a step (II) to divide the mixture into a retentate and a permeate, the solids content in the retentate being higher than that in the mixture and the solids content in the permeate being lower than that in the mixture. This procedure allows auxiliaries, in particular template compounds, present in the permeate to be recycled into a crystallizing step (I) upstream of step (II).

    Abstract translation: 在将包含至少一种沸石的至少部分结晶的固体在包含至少一种助剂例如模板化合物和所述固体的混合物中浓缩的方法中，在步骤（II）中将混合物超滤以将混合物分成 渗余物和渗透物，渗余物中的固体含量高于混合物中的固体含量，并且渗透物中的固体含量低于混合物中的固体含量。 该方法允许存在于渗透物中的助剂，特别是模板化合物再循环到步骤（II）上游的结晶步骤（I）中。

    Benzylhydroxylamines and intermediates used to prepare them
    4.
    发明授权
    Benzylhydroxylamines and intermediates used to prepare them 失效

    公开(公告)号：US6057269A

    公开(公告)日：2000-05-02

    申请号：US973780

    申请日：1998-01-05

    Applicant: Ralf Klintz ,  Gerhard Hamprecht ,  Elisabeth Heistracher ,  Peter Schafer ,  Cyrill Zagar ,  Karl-Otto Westphalen ,  Helmut Walter ,  Ulf Misslitz ,  Olaf Menke ,  Markus Menges

    Inventor： Ralf Klintz ,  Gerhard Hamprecht ,  Elisabeth Heistracher ,  Peter Schafer ,  Cyrill Zagar ,  Karl-Otto Westphalen ,  Helmut Walter ,  Ulf Misslitz ,  Olaf Menke ,  Markus Menges

    IPC: A01N43/54 ,  A01N47/12 ,  A01N47/24 ,  A01N47/30 ,  A01N53/00 ,  C07C239/08 ,  C07C239/10 ,  C07C239/16 ,  C07C239/20 ,  C07C265/12 ,  C07C271/22 ,  C07C271/28 ,  C07C271/54 ,  C07C271/58 ,  C07C275/32 ,  C07C275/40 ,  C07D239/54 ,  C07D405/12

    CPC classification number: C07D239/54 ,  A01N43/54 ,  A01N47/12 ,  A01N47/24 ,  A01N47/30 ,  A01N53/00 ,  C07C239/08 ,  C07C239/10 ,  C07C265/12 ,  C07C271/22 ,  C07C271/28 ,  C07C271/54 ,  C07C271/58 ,  C07C275/40

    Abstract: Benzylhydroxylamines I ##STR1## (X=--N(R.sup.7)--O--; Y=O, S; R.sup.1 =halogen, CN, NO.sub.2, CF.sub.3 ; R.sup.2 =H, halogen; R.sup.3 =H, NH.sub.2, CH.sub.3 ;R.sup.4 =H, halogen, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.1 -C.sub.6 -alkylthio, C.sub.1 -C.sub.6 -alkylsulfinyl or C.sub.1 -C.sub.6 -alkylsulfonyl;R.sup.5 =H, halogen, C.sub.1 -C.sub.6 -alkyl;R.sup.6 =H, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.3 -C.sub.6 -cycloalkyl, C.sub.2 -C.sub.6 -alkenyl;R.sup.7 =H, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.3 -C.sub.6 -alkenyl, C.sub.3 -C.sub.6 -alkynyl, C.sub.1 -C.sub.6 -alkylcarbonyl, C.sub.3 -C.sub.6 -alkenylcarbonyl, C.sub.3 -C.sub.6 -alkynylcarbonyl, C.sub.1 -C.sub.6 -alkoxycarbonyl, C.sub.2 -C.sub.8 -alkenyloxycarbonyl, C.sub.2 -C.sub.6 -alkynyloxycarbonyl, C.sub.1 -C.sub.6 -alkylthiocarbonyl, C.sub.1 -C.sub.6 -alkylsulfonyl, C.sub.1 -C.sub.6 -alkylcarbamoyl, it being possible for the 14 last-mentioned radicals to have attached to them 1-3 substituents:NO.sub.2, CN, halogen, C.sub.3 -C.sub.8 -cycloalkyl, OH, C.sub.1 -C.sub.6 -alkoxy, C.sub.3 -C.sub.8 -cycloalkoxy, C.sub.3 -C.sub.6 -alkenyloxy, C.sub.3 -C.sub.6 -alkynyloxy, C.sub.1 -C.sub.6 -alkoxy-C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.6 -alkylthio, C.sub.1 -C.sub.6 -alkylcarbonyl, C.sub.1 -C.sub.6 -alkylcarbonyloxy, C.sub.1 -C.sub.6 -alkylsulfinyl, C.sub.1 -C.sub.6 -alkylsulfonyl, C.sub.1 -C.sub.6 -alkylideneaminoxy, C.sub.1 -C.sub.6 -alkylcarbamoyl,unsubstituted or substituted phenyl, phenoxy or phenylsulfonyl,a 3- to 7-membered heterocyclyl or heterocyclyloxy group having 1-3 hetero atoms, it being possible for this group to be saturated, unsaturated or aromatic and to have attached to it 1-3 substituents,--CO--Z.sup.1 R.sup.9, --OCO--Z.sup.1 R.sup.9, --N(R.sup.9)R.sup.10 orR.sup.7 =unsubstituted or substituted cycloalkylcarbonyl, phenylcarbonyl, phenylsulfonyl, phenylcarbamoyl;R.sup.8 =H, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.3 -C.sub.6 -alkenyl or C.sub.3 -C.sub.6 -alkynyl, it being possible for each of the 5 last-mentioned radicals to have attached to it 1-3 substituents:NO.sub.2, CN, halogen, C.sub.3 -C.sub.8 -cycloalkyl, OH, C.sub.1 -C.sub.6 -alkoxy, C.sub.3 -C.sub.8 -cycloalkoxy, C.sub.3 -C.sub.6 -alkenyloxy, C.sub.3 -C.sub.6 -alkynyloxy, C.sub.1 -C.sub.6 -alkoxy-C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.6 -alkylthio, C.sub.1 -C.sub.6 -alkylsulfinyl, C.sub.1 -C.sub.6 -alkylsulfonyl, C.sub.1 -C.sub.6 -alkylideneaminoxy,unsubstituted or substituted phenyl- [sic], phenoxy-[sic] or phenylsulfonyl,a 3- to 7-membered heterocyclyl or heterocyclyloxy group having 1-3 hetero atoms, it being possible for this group to be saturated, unsaturated or aromatic and to have attached to it 1-3 substituents,--CO--Z.sup.2 R.sup.11, --OCO--Z.sup.2 R.sup.11, --N(R.sup.11)R.sup.12 ;Z.sup.1 a chemical bond, oxygen, sulfur or --N(R.sup.10)--;Z.sup.2 =a chemical bond, oxygen, sulfur or --N(R.sup.12)--;R.sup.9, R.sup.11 =H, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.3 -C.sub.6 -alkenyl, C.sub.3 -C.sub.6 -alkynyl, C.sub.1 -C.sub.6 -alkoxy-C.sub.1 -C.sub.6 -alkyl, (C.sub.1 -C.sub.6 -alkoxy)carbonyl-C.sub.1 -C.sub.6 -alkyl, unsubstituted or substituted phenyl or phenyl-C.sub.1 -C.sub.6 -alkyl,orZ.sup.1 and R.sup.9 and/or Z.sup.2 and R.sup.11 together=a 3- to 7-membered heterocycle having 1-3 hetero atoms and bonded via nitrogen, it being possible for this heterocycle to be saturated, unsaturated or aromatic and, if desired, to have attached to it one to three substituents,R.sup.10, R.sup.12 =H, OH, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.1 -C.sub.6 -alkoxy)and the salts of I where R.sup.3, R.sup.7 and/or R.sup.8 =hydrogenare used as herbicides and for the desiccation/defoliation of plants.

    Color photographic developer concentrate
    8.
    发明授权
    Color photographic developer concentrate 失效
    彩色照相显影剂浓缩液

    公开(公告)号：US06251574B1

    公开(公告)日：2001-06-26

    申请号：US09593430

    申请日：2000-06-14

    Applicant: Thomas Hübsch

    Inventor： Thomas Hübsch

    IPC: G03C7413

    CPC classification number: C07C259/06 ,  C07C239/08 ,  C07C239/12 ,  C07C309/14 ,  G03C5/266 ,  G03C7/3022 ,  G03C7/413 ,  G03C2001/03517

    Abstract: A one-part, multi-phase colour developer concentrate having an aqueous phase and an organic phase, wherein the organic phase is constituted by a carboxylic acid amide or urea derivative which is liquid at room temperature and the concentrate contains at least one compound of the formulae (I), (II) or (III) as antioxidant: in which R1 means alkyl, R2 means alkyl or aryl and n means 0 or 1 and at least one of the residues R1 and R2 contains at least one —OH, —COOH or —SO3H group; in which R3 means an alkyl or acyl group; in which R4 means an alkylene group optionally interrupted by O atoms and m means a number of at least 2, is in particular suitable for the production of a colour developer solution for silver halide materials having an elevated AgCl content.

    Abstract translation: 一种具有水相和有机相的单组分多相显色剂浓缩物，其中有机相由在室温下为液体的羧酸酰胺或脲衍生物构成，并且浓缩物含有至少一种化合物 式（I），（II）或（III）作为抗氧化剂：其中R 1表示烷基，R 2表示烷基或芳基，并且表示0或1，并且残基R 1和R 2中的至少一个含有至少一个-OH，-COOH或 - SO 3 H基团;其中R 3表示烷基或酰基;其中R 4表示任选被O原子间隔的亚烷基，m表示至少2个数，特别适用于制备具有 AgCl含量升高。

    Process for the preparation of a hydroxylamine
    9.
    发明授权
    Process for the preparation of a hydroxylamine 失效
    制备羟胺的方法

    公开(公告)号：US5166435A

    公开(公告)日：1992-11-24

    申请号：US177836

    申请日：1988-03-24

    Applicant: Ashutosh H. Sharma ,  Peter Hope

    Inventor： Ashutosh H. Sharma ,  Peter Hope

    IPC: C07C239/08

    CPC classification number: C07C239/08

    Abstract: The present invention relates to a process for the preparation of organic hydroxylamines as a result of the corresponding nitroderivative being hydrogenated in the presence of an inert solvent, a platinum catalyst, a nitrogen-containing base (in an amount of less than 10% by weight calculated on the amount of nitro derivative) and a tri- or pentavalent organic phosphorus compound. It has been found that if only use is made of the nitrogen-containing base or the phosphorus compound the yields of isolated hydroxyl amine are significantly reduced in comparison with those obtained with the present process.

    Abstract translation: 本发明涉及一种制备有机羟胺的方法，其中相应的硝基衍生物在惰性溶剂，铂催化剂，含氮碱（其含量小于10重量％ 根据硝基衍生物的量计算）和三价或五价有机磷化合物。 已经发现，如果仅使用含氮碱或磷化合物，则与本方法获得的相比，分离的羟胺的产率显着降低。

    Synthetic Ion Channels
    10.
    发明申请
    Synthetic Ion Channels 有权
    合成离子通道

    公开(公告)号：US20130244944A1

    公开(公告)日：2013-09-19

    申请号：US13731971

    申请日：2012-12-31

    Applicant: Dan Yang ,  Xiang Li ,  Huiyan Zha

    Inventor： Dan Yang ,  Xiang Li ,  Huiyan Zha

    IPC: C07C335/16 ,  C07C259/06 ,  C07C275/28 ,  C07K5/062

    CPC classification number: C07C335/16 ,  C07B2200/07 ,  C07C237/22 ,  C07C239/08 ,  C07C239/20 ,  C07C259/06 ,  C07C271/22 ,  C07C275/28 ,  C07D213/63 ,  C07D213/79 ,  C07D213/81 ,  C07K5/06034

    Abstract: Provided herein are self-assembling compounds that can form ion channels in lipid bilayers or cell membranes and ion-channel-forming compositions comprising the self-assembling compounds. Also provided are methods of making and using the ion channels formed from a plurality of molecules of the self-assembling compounds. Further, provided are methods of treating or preventing conditions and diseases that are related to the dysfunction of ion channels, including chloride channels.

    Abstract translation: 本文提供了可以在脂质双层或细胞膜中形成离子通道的自组装化合物和包含自组装化合物的离子通道形成组合物。 还提供了制造和使用由多个自组装化合物分子形成的离子通道的方法。 此外，提供了治疗或预防与离子通道功能障碍（包括氯化物通道）相关的病症和疾病的方法。

Patent Agency Ranking